These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25327875)

  • 21. Electrical conductivity changes during irreversible electroporation treatment of brain cancer.
    Garcia PA; Rossmeisl JH; Davalos RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():739-42. PubMed ID: 22254416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental characterization of intrapulse tissue conductivity changes for electroporation.
    Neal RE; Garcia PA; Robertson JL; Davalos RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5581-4. PubMed ID: 22255604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible electroporation: implications for prostate ablation.
    Onik G; Mikus P; Rubinsky B
    Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings.
    Agnass P; Rodermond HM; Zweije R; Sijbrands J; Vogel JA; van Lienden KP; van Gulik TM; van Veldhuisen E; Franken NAP; Oei AL; Kok HP; Besselink MG; Crezee J
    Sensors (Basel); 2020 Oct; 20(21):. PubMed ID: 33142821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological Response to 5 kHz Irreversible Electroporation in a Porcine Liver Model.
    Kim HB; Baik KY; Sung CK
    Technol Cancer Res Treat; 2023; 22():15330338231171767. PubMed ID: 37125478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversible electroporation is a thermally mediated ablation modality for pulses on the order of one microsecond.
    Fesmire CC; Petrella RA; Kaufman JD; Topasna N; Sano MB
    Bioelectrochemistry; 2020 Oct; 135():107544. PubMed ID: 32438309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
    Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
    Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).
    Kos B; Voigt P; Miklavcic D; Moche M
    Radiol Oncol; 2015 Sep; 49(3):234-41. PubMed ID: 26401128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation.
    Scheffer HJ; Vogel JA; van den Bos W; Neal RE; van Lienden KP; Besselink MG; van Gemert MJ; van der Geld CW; Meijerink MR; Klaessens JH; Verdaasdonk RM
    PLoS One; 2016; 11(2):e0148457. PubMed ID: 26844550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of dispersion and anisotropic-conductivity in tissue model during electroporation pulses.
    Guo F; Deng H; Qian K; Li X
    Bioelectrochemistry; 2022 Apr; 144():108029. PubMed ID: 34894430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
    Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy.
    O'Brien TJ; Lorenzo MF; Zhao Y; Neal Ii RE; Robertson JL; Goldberg SN; Davalos RV
    Int J Hyperthermia; 2019; 36(1):953-963. PubMed ID: 31542973
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models.
    Neal RE; Garcia PA; Kavnoudias H; Rosenfeldt F; Mclean CA; Earl V; Bergman J; Davalos RV; Thomson KR
    IEEE Trans Biomed Eng; 2015 Feb; 62(2):561-9. PubMed ID: 25265626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis on reversible/irreversible electroporation region in lung adenocarcinoma cell model in vitro with electric pulses delivered by needle electrodes.
    Lv Y; Tang X; Peng W; Cheng X; Chen S; Yao C
    Phys Med Biol; 2020 Nov; 65(22):225001. PubMed ID: 33053520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of irreversible electroporation on three-dimensional cell culture model.
    Kurata K; Matsushita M; Yoshii T; Fukunaga T; Takamatsu H
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():179-82. PubMed ID: 23365861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible electroporation: a new ablation modality--clinical implications.
    Rubinsky B; Onik G; Mikus P
    Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
    Neal RE; Davalos RV
    Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Irreversible electroporation. Current value for focal treatment of prostate cancer].
    Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB;
    Urologe A; 2015 Jun; 54(6):854-62. PubMed ID: 26024649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.